Pharmacokinetic profile of an intradeltoid diclofenac injection in obese Indian volunteers
Author(s) -
Vijaya Jaiswal,
Ojha,
Patel,
Nivsarkar,
Padh,
Shep
Publication year - 2010
Publication title -
journal of pain research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 49
ISSN - 1178-7090
DOI - 10.2147/jpr.s13894
Subject(s) - bioequivalence , pharmacokinetics , bioavailability , diclofenac sodium , diclofenac , medicine , crossover study , chromatography , pharmacology , chemistry , alternative medicine , pathology , placebo
A new propylene glycol-free and reduced-volume formulation of diclofenac sodium 75 mg/mL designed for intradeltoid administration has been found to be bioequivalent to a reference formulation of diclofenac sodium 75 mg/3 mL given via the intragluteal route in normal healthy volunteers. Standard needles may not reach the gluteus maximus muscle in many cases, especially in the obese. The objective of this study was to determine the pharmacokinetic parameters of the new formulation and compare the bioavailability of intradeltoid diclofenac sodium 75 mg/mL with that of the intragluteal 75 mg/3 mL reference formulation in obese volunteers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom